Cause of death, by non-communicable diseases, ages 60+, male in Libya
Libya: Cause of death, by non-communicable diseases, ages 60+, male was 67.7% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 60+, male in Libya, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 60+.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 60+, male in Libya is 67.7%, measured in 2021. That is the lowest value across all 6 years on record.
The figure is down 14.7% on the previous year and down 25.2% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, male in Libya peaked at 90.6% in 2010 and was at its lowest, 67.7%, in 2021.
That places Libya 98th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 60+, male in Libya, year by year
| Year | % of total male deaths ages 60+ | Change |
|---|---|---|
| 2000 | 88.8% | — |
| 2010 | 90.6% | +2.0% |
| 2015 | 88.2% | -2.6% |
| 2019 | 90.2% | +2.3% |
| 2020 | 79.4% | -12.0% |
| 2021 | 67.7% | -14.7% |
Libya compared with similar countries
- Libya's 67.7% is above the median for upper middle income countries, which is 67.7%, 1.0× the median. (55 countries reporting)
- Libya's 67.7% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 70.5%, 96% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 88.8% | 88.8% | 88.8% | 1 |
| 2010s | 89.7% | 88.2% | 90.6% | 3 |
| 2020s | 73.6% | 67.7% | 79.4% | 2 |
Countries ranked near Libya
More health data for Libya
- Un projection of annual infant deaths, annual growth rate -1.48 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,084 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0404 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, male in Libya?
- Cause of death, by non-communicable diseases, ages 60+, male in Libya was 67.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, male recorded in Libya?
- The highest recorded value was 90.6% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, male recorded in Libya?
- The lowest recorded value was 67.7% in 2021.
- How does Libya rank for cause of death, by non-communicable diseases, ages 60+, male?
- Libya ranks 98th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, male rising or falling in Libya?
- Over the last ten years it is down 25.2%. The long-run trend across the full record is falling.
- Where does this Libya data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.